Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication

NCT: NCT06049654 · RECRUITING

NCT IDNCT06049654
StatusRECRUITING
Start Date2024-02-01
Completion2027-11-01
SponsorFundación EPIC (OTHER)
First posted
Last updated

Brief Summary

The VIVALL-2 study is a randomized trial to compare the self-expandable supra-annular Allegra and the balloon-expandable intra-annular Edwards transcatheter valve systems in patients with degenerated biological aortic surgical valve.

Frequently Asked Questions

What is Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication?

Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication is a clinical trial registered under NCT06049654. Current status: RECRUITING.

What is the status of NCT06049654?

The current status of NCT06049654 (Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication) is: RECRUITING.

When did Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication start?

Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication started on 2024-02-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.